Drugs / Intravenous Immunoglobulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00231439 | Aug 2003 → Jul 2004 | postpoliomyelitis syndrome | Haukeland University Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intravenous Immunoglobulin | “Post-Polio Syndrome Treated With Intravenous Immunoglobulin (IvIg)” NCT00231439 ↗ |
| Known as | IvIg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00231439 ↗ |
| Modality | Protein / enzyme biologic | “Intravenous Immunoglobulin” NCT00231439 ↗ |
| Route | Intravenous | “Treated With Intravenous Immunoglobulin” NCT00231439 ↗ |